LPV Strategies Require Adjustment for ARDS Management in Achondroplasia
-
Regional Pockets of HAE Persist Due to Founder Effect, Affecting Generations of FamiliesHAE affects approximately 1 in 50,000 people globally, but is far more prevalent in a few select geographic regions.
-
New Prader-Willi Therapy Gives Parents Rare Hope for Managing HyperphagiaDiazoxide choline is believed to activate the ATP-sensitive potassium channel, which may decrease secretion of peptides that regulate appetite.
-
GBS/CIDP Foundation Helps Promote Awareness of Rare Debilitating NeuropathyThe GBS/CIDP Foundation International aims to provide support, with an emphasis on patients and caregivers meeting each other.
-
Advocates Seek Solutions After HHS Ends Newborn Screening Advisory PanelNewborn screening in the US currently identifies about 14,000 babies with serious conditions annually.
-
North Carolina Teen With Charcot-Marie-Tooth Disease Is MDA’s 2025 National AmbassadorLily Sander has an especially rare type of Charcot-Marie-Tooth (CMT) disease—a mutation that occurs in just 1% of those with CMT.
-
Steroids: The Good, the Bad, the Ugly for ITPPatients with a relapse of immune thrombocytopenia (ITP) are often prescribed steroid treatment, which can come with difficult side effects.May 9, 2025
-
Is There a Connection Linking AATD and Atrial Fibrillation?Knowing a potential connection between alpha-1 antitrypsin deficiency (AATD) and atrial fibrillation helps patients be aware of complications.May 9, 2025
-
Telling Others About CAD Is No Easy TaskPatients with cold agglutinin disease (CAD) can find it difficult to explain their rare disease diagnosis or living experience to others.May 7, 2025
-
Finding Inspiration, Deeper Knowledge at WODC 2025I am still excited and motivated by what I experienced at this year's World Orphan Drug Congress.May 7, 2025
-
Pivoting Toward Patient-Reported Outcomes in Systemic MastocytosisIncreasingly, modern medicine is making room for patients to better express themselves through self-reported outcomes, especially for rare diseases like SM.
-
Rituximab May Play a Key Role in Refractory CIDPStudies suggest that rituximab may have a significant role to play in patients who have been diagnosed with refractory CIDP.
-
Evaluating Challenges in the Management of GPP TodaySignificant gaps remain in the clinical management of generalized pustular psoriasis (GPP), including guidelines on long-term chronic care.
-
AAV and IgG4-RD Share Similar Clinical and Laboratory FindingsResearchers investigated the apparent close relationship between IGG4-RD and AAV and whether they arise from shared pathophysiological pathways.
-
Fibrates May Be a Second-Line Therapy Option in PBC-Related Intractable Pruritus in PregnancyFibrates was used as second-line therapy in a pregnant patient with PBC-associated pruritus who responded poorly to UDCA, a study found.

- Achondroplasia
- Acute Lymphoblastic Leukemia
- Alagille Syndrome
- Alpha-1 Antitrypsin Deficiency
- ANCA-Associated Vasculitis
- Cholangiocarcinoma
- Chronic Inflammatory Demyelinating Polyneuropathy
- Chronic Lymphocytic Leukemia
- Cold Agglutinin Disease
- Cystic Fibrosis
- Diffuse Large B-Cell Lymphoma
- Dravet Syndrome
- Duchenne Muscular Dystrophy
- Fabry Disease
- Fetal and Neonatal Alloimmune Thrombocytopenia
- Friedreich Ataxia
- Gastrointestinal Stromal Tumor
- Gaucher Disease
- Generalized Pustular Psoriasis
- Hemolytic Disease of the Fetus and Newborn
- Hemophilia
- Hepatocellular Carcinoma
- Hereditary Angioedema
- Huntington Disease
- Idiopathic Pulmonary Fibrosis
- IgG4-Related Disease
- Immune Thrombocytopenia
- Lennox-Gastaut Syndrome
- Long Chain Fatty Acid Oxidation Disorder
- Lysosomal Acid Lipase Deficiency
- Medullary Thyroid Carcinoma
- Multiple Sclerosis
- Myasthenia Gravis
- Myelodysplastic Syndromes
- Myelofibrosis
- Neuromyelitis Optica Spectrum Disorder
- Paroxysmal Nocturnal Hemoglobinuria
- Pompe Disease
- Prader-Willi Syndrome
- Primary Biliary Cholangitis
- Primary Central Nervous System Lymphoma
- Pulmonary Arterial Hypertension
- Sickle Cell Disease
- Spinal Muscular Atrophy
- Systemic Mastocytosis
- Systemic Sclerosis
- Thymidine Kinase 2 Deficiency
- Transthyretin Amyloid Polyneuropathy
- Transthyretin-Mediated Amyloid Cardiomyopathy
- Wilson Disease